Neuronal and glial β‐secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Neuroscience Research

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jnr.1095PMID 11391698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology

  2001cited by this paper
• beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging.

  2001cited by this paper
• Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.

  2001cited by this paper
• Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties.

  2000cited by this paper
• Proteolytic processing and cell biological functions of the amyloid precursor protein.

  2000cited by this paper
• Maturation and pro-peptide cleavage of beta-secretase.

  2000cited by this paper
• A Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase*

  2000cited by this paper
• The β-Amyloid Precursor Protein and its Derivatives: From Biology to Learning and Memory Processes

  2000cited by this paper
• Induction of cytokines in glial cells surrounding cortical β‐amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

  2000influential reference
• Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase.

  2000cited by this paper
• Characterization of Alzheimer's β-Secretase Protein BACE

  2000cited by this paper
• Constitutive overactivation of protein kinase C in guinea pig brain increases α‐secretory APP processing without decreasing β‐amyloid generation

  2000cited by this paper
• Maturation and Pro-peptide Cleavage of β-Secretase*

  2000cited by this paper
• Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation.

  2000cited by this paper
• Cellular and molecular basis of beta-amyloid precursor protein metabolism.

  2000cited by this paper
• Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology

  2000influential reference
• Intracerebroventricular infusion of CHO5, a rat monoclonal antibody directed against mouse low-affinity nerve growth factor receptor (p75NTR), specifically labels basal forebrain cholinergic neurons in mouse brain

  2000cited by this paper
• Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.

  2000cited by this paper
• Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme

  2000cited by this paper
• Cellular and molecular basis of b-amyloid precursor protein metabolism (Y2K update)

  2000cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

  1999cited by this paper
• Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice.

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.

  1999cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

  1998cited by this paper
• Expression of amyloid precursor protein mRNA isoforms in rat brain is differentially regulated during postnatal maturation and by cholinergic activity

  1997cited by this paper
• Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

  1997cited by this paper
• Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*

  1997cited by this paper
• In Vivo Regulation of Amyloid Precursor Protein Secretion in Rat Neocortex by Cholinergic Activity

  1997cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996influential reference
• Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide

  1993cited by this paper
• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

  1993cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• Beta-amyloid precursor protein cleavage by a membrane-bound protease.

  1992cited by this paper
• Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

  1992cited by this paper
• Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

  1992cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper

• Microglial, astrocytic, oligodendrocyte, B-/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias.

  2026cites this paper
• The causative role of amyloidosis in the cardiac complications of Alzheimer's disease: a comprehensive systematic review

  2025cites this paper
• Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease Model of Alzheimer's Disease

  2022cites this paper
• Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

  2021cites this paper
• Contribution of astrocytes to neuropathology of neurodegenerative diseases.

  2021cites this paper
• Regulation of BACE1 expression after injury is linked to the p75 neurotrophin receptor.

  2019cites this paper
• Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain

  2019cites this paper
• A role for astrocyte‐derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy

  2018cites this paper
• &agr;-secretase ADAM10 physically interacts with &bgr;-secretase BACE1 in neurons and regulates CHL1 proteolysis

  2018cites this paper
• Sex‐dependent co‐occurrence of hypoxia and &bgr;‐amyloid plaques in hippocampus and entorhinal cortex is reversed by long‐term treatment with ubiquinol and ascorbic acid in the 3 × Tg‐AD mouse model of Alzheimer's disease

  2018cites this paper
• Kainate Receptor Activation Enhances Amyloidogenic Processing of APP in Astrocytes

  2018cites this paper
• Astrocytes and synaptic plasticity in health and disease

  2017cites this paper
• Diversity of astroglial responses across human neurodegenerative disorders and brain aging

  2017cites this paper
• Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease

  2017cites this paper
• Glial Cells - The Key Elements of Alzheimer´s Disease.

  2016cites this paper
• PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA.

  2016cites this paper
• miR‐186 is decreased in aged brain and suppresses BACE1 expression

  2016cites this paper
• Phenotypic Pattern of Astrocyte Activation in Response to Aging and Alzheimer's-Like Pathology in Chimpanzees

  2016cites this paper
• The role of pattern recognition receptors in amyloid-beta-induced inflammation

  2016cites this paper
• Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents

  2015cites this paper
• Cholesterol‐induced astrocyte activation is associated with increased amyloid precursor protein expression and processing

  2015cites this paper
• Investigation of BACE1 as a stress-induced regulator of neuronal metabolism

  2014cites this paper
• Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage.

  2014cites this paper
• Neurodegeneration and Neuroglia: Emphasis on Astroglia in Alzheimer’s Disease

  2014cites this paper
• When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.

  2014cites this paper
• Picomolar Amyloid-β Peptides Enhance Spontaneous Astrocyte Calcium Transients

  2013cites this paper
• The Guinea Pig as a Model for Sporadic Alzheimer’s Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes

  2013cites this paper
• The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol‐mediated intracellular amyloid β toxicity via its impaired cholesterol efflux

  2013cites this paper
• BACE1 and presenilin/γ‐secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage‐gated potassium channels

  2013cites this paper
• Monitoring Alzheimer's disease in transgenic mice with ultra high field magnetic resonance imaging

  2013cites this paper
• Cortical astroglial atrophy in ageing and Alzheimer's disease

  2013cites this paper
• BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

  2012cites this paper
• The cellular nucleic acid binding protein regulates the Alzheimer's disease beta-secretase protein BACE1

  2012cites this paper
• Aβ-induced Ca(2+) influx regulates astrocytic BACE1 expression via calcineurin/NFAT4 signals.

  2012cites this paper
• β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis

  2012cites this paper
• Adaptor protein 2–mediated endocytosis of the β-secretase BACE1 is dispensable for amyloid precursor protein processing

  2012cites this paper
• Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE)

  2012cites this paper
• Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease

  2012cites this paper
• TargetingAstrocytesAmelioratesNeurologicChangesina MouseModelofAlzheimer'sDisease

  2012cites this paper
• Focus on NF-κB and C/EBP transcription factors

  2011cites this paper
• The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy

  2011cites this paper
• HIV-1 Reduces Aβ-Degrading Enzymatic Activities in Primary Human Mononuclear Phagocytes

  2011cites this paper
• β‐Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression

  2011cites this paper
• Aged PrP null mice show defective processing of neuregulins in the peripheral nervous system.

  2011cites this paper
• Astrocytes in Alzheimer’s disease

  2010cites this paper
• Age- and Sex-Associated Changes in mRNA Expression of Neurodegenerative Disorder-Related Molecules in the Hippocampus and Cerebellum of Rat Brain

  2010cites this paper
• Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

  2010cites this paper
• Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing.

  2010cites this paper
• Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann‐Pick type C1‐deficient mouse brains

  2010cites this paper
• β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

  2009cites this paper
• The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era

  2009cites this paper
• Neuronal protein trafficking associated with Alzheimer disease

  2009cites this paper
• Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain

  2009cites this paper
• Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice.

  2009cites this paper
• Alzheimer's Disease BACE Proteases

  2008cites this paper
• BACE1 structure and function in health and Alzheimer's disease.

  2008cites this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cites this paper
• Protein expression of BACE1, BACE2 and APP in Down syndrome brains

  2008cites this paper
• Platelet beta-secretase activity is increased in Alzheimer's disease.

  2008cites this paper
• Caspase inhibition attenuates accumulation of beta-amyloid by reducing beta-secretase production and activity in rat brains after stroke.

  2008cites this paper
• Stress Response Signal Transduction

  2008cites this paper
• APPSWE Microinjected Mouse Model | Taconic Biosciences

  2008cites this paper
• Interactions between APP secretases and inflammatory mediators

  2008cites this paper
• Platelet β-secretase activity is increased in Alzheimer's disease

  2008cites this paper
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007cites this paper
• The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease

  2007cites this paper
• Characterization of the human β-secretase 2 (BACE2) 5′-flanking region

  2007cites this paper
• IFN‐γ‐induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes

  2007cites this paper
• Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

  2007cites this paper
• BACE1 Expression and Activity: Relevance in Alzheimer’s Disease

  2007cites this paper
• Interferon-(cid:2) and Tumor Necrosis Factor-(cid:3) Regulate Amyloid-(cid:4) Plaque Deposition and (cid:4) -Secretase Expression in Swedish Mutant APP Transgenic Mice

  2007cites this paper
• Secretase Processing of Amyloid Precursor Protein (APP) and Neurodegeneration

  2007cites this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007cites this paper
• Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

  2007cites this paper
• -SiteAmyloidPrecursorProteinCleavingEnzyme1Levels BecomeElevatedinNeuronsaroundAmyloidPlaques: ImplicationsforAlzheimer'sDiseasePathogenesis

  2007cites this paper
• The Alzheimer's disease β-secretase enzyme, BACE1

  2007cites this paper
• Identification of a BACE dimer and characterization of its biochemical and enzymatic properties

  2006cites this paper
• Characterization of the human beta-secretase 2 (BACE2) 5'-flanking region: identification of a 268-bp region as the basal BACE2 promoter.

  2006cites this paper
• Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer‐like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein

  2006cites this paper
• LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease

  2006cites this paper
• Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models

  2006cites this paper
• The transcription factor Yin Yang 1 is an activator of BACE1 expression

  2006cites this paper
• Dopamine-induced stress signaling in COS-7 cells transfected with selectively vulnerable muscarinic receptor subtypes is partially mediated via the i3 loop and antagonized by blueberry extract

  2006cites this paper
• Synaptic remodeling during aging and in Alzheimer's disease

  2006cites this paper
• Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.

  2006cites this paper
• Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling

  2005cites this paper
• Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.

  2005cites this paper
• Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.

  2005cites this paper
• PAR-4 Is Involved in Regulation of β-Secretase Cleavage of the Alzheimer Amyloid Precursor Protein*

  2005cites this paper
• Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme

  2005influential citation
• High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels

  2005cites this paper
• Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

  2005cites this paper
• High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease.

  2005cites this paper
• Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.

  2005cites this paper
• Neuronal and Nonneuronal Quantitative BACE Immunocytochemical Expression in the Entorhinohippocampal and Frontal Regions in Alzheimer’s Disease

  2005cites this paper
• Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

  2005cites this paper
• The role of Abeta peptides in Alzheimer's disease.

  2005cites this paper
• Down‐regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease‐relevant genes and proteins

  2005cites this paper
• Expression and activity of β-site amyloid precursor protein cleaving enzyme in Alzheimer's disease

  2005cites this paper
• Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression

  2004cites this paper